Advertisement
Screener

ADMA BIOLOGICS, INC. (ADMA) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

ADMA BIOLOGICS, INC. Shares Authorized

ADMA BIOLOGICS, INC. (ADMA) had Shares Authorized of 300.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-05

  • 2026-06-30: Common Stock, Shares Authorized 300.00M shares.
  • 2026-03-31: Common Stock, Shares Authorized 300.00M shares.
  • 2025-12-31: Common Stock, Shares Authorized 300.00M shares.
  • 2025-09-30: Common Stock, Shares Authorized 300.00M shares.
Period endCommon Stock, Shares AuthorizedCommon Stock, Shares Authorized as first filed
2026-06-30300.00M shares
10-Q · filed 2026-08-05
2026-03-31300.00M shares
10-Q · filed 2026-05-06
2025-12-31300.00M shares
10-Q · filed 2026-08-05
2025-09-30300.00M shares
10-Q · filed 2025-11-05
2025-06-30300.00M shares
10-Q · filed 2025-08-06
2025-03-31300.00M shares
10-Q · filed 2025-05-07
2024-12-31300.00M shares
10-K · filed 2026-02-25
2024-09-30300.00M shares
10-Q · filed 2024-11-07
2024-06-30300.00M shares
10-Q · filed 2024-08-08
2024-03-31300.00M shares
10-Q · filed 2024-05-09
2023-12-31300.00M shares
10-K · filed 2025-03-18
2023-09-30300.00M shares
10-Q · filed 2023-11-08
2023-06-30300.00M shares
10-Q · filed 2023-08-09
2023-03-31300.00M shares
10-Q · filed 2023-05-10
2022-12-31300.00M shares
10-K · filed 2024-02-28
2022-09-30300.00M shares
10-Q · filed 2022-11-09
2022-06-30300.00M shares
10-Q · filed 2022-08-10
2022-03-31300.00M shares
10-Q · filed 2022-05-11
2021-12-31300.00M shares
10-K · filed 2023-03-23
2021-09-30300.00M shares
10-Q · filed 2021-11-10
2021-06-30300.00M shares
10-Q · filed 2021-08-11
2021-05-27150.00M shares
10-K · filed 2022-03-24
2021-03-31150.00M shares
10-Q · filed 2021-05-12
2020-12-31150.00M shares
10-K · filed 2022-03-24
2020-09-30150.00M shares
10-Q · filed 2020-11-05
2020-06-30150.00M shares
10-Q · filed 2020-08-05
2020-03-31150.00M shares
10-Q · filed 2020-05-06
2019-12-31150.00M shares
10-K · filed 2021-03-25
2019-09-30150.00M shares
10-Q · filed 2019-11-06
2019-08-23150.00M shares
10-K · filed 2021-03-25
2019-06-3075.00M shares
10-Q · filed 2019-08-08
2019-03-3175.00M shares
10-Q · filed 2019-05-08
2018-12-3175.00M shares
10-K · filed 2020-03-13
2018-09-3075.00M shares
10-Q · filed 2018-11-09
2018-06-3075.00M shares
10-Q · filed 2018-08-10
2018-03-3175.00M shares
10-Q · filed 2018-05-14
2017-12-3175.00M shares
10-K · filed 2019-03-13
2017-09-3075.00M shares
10-Q · filed 2017-11-03
2017-06-3075.00M shares
10-Q · filed 2017-08-11
2017-03-3175.00M shares
10-Q · filed 2017-05-12
2016-12-3175.00M shares
10-K · filed 2018-03-29
2016-09-3075.00M shares
10-Q · filed 2016-11-10
2016-06-3075.00M shares
10-Q · filed 2016-08-12
2016-03-3175.00M shares
10-Q · filed 2016-05-13
2015-12-3175.00M shares
10-K · filed 2017-02-24
2015-09-3075.00M shares
10-Q · filed 2015-11-10
2015-06-3075.00M shares
10-Q · filed 2015-08-11
2015-03-3175.00M shares
10-Q · filed 2015-05-12
2014-12-3175.00M shares
10-K · filed 2016-03-23
2014-09-3075.00M shares
10-Q · filed 2014-11-10
2014-06-3075.00M shares
10-Q · filed 2014-08-11
2014-03-3175.00M shares
10-Q · filed 2014-05-12
2013-12-3175.00M shares
10-K · filed 2015-03-09
2013-09-3075.00M shares
10-Q · filed 2013-11-12
2013-06-3075.00M shares
10-Q · filed 2013-08-12
2013-03-3175.00M shares
10-Q · filed 2013-05-14
2012-12-3175.00M shares
10-K · filed 2014-03-28
2012-09-3075.00M shares
10-Q · filed 2012-11-13
2012-06-3075.00M shares
10-Q · filed 2012-08-14
2012-03-3175.00M shares
10-Q · filed 2012-05-15
2011-12-316.50M shares
10-K · filed 2013-03-06
75.00M shares
10-Q · filed 2012-02-01
2011-09-3075.00M shares
10-Q · filed 2011-10-28
2011-06-3075.00M shares
10-Q · filed 2012-02-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43